Agility Health Tech is delighted to announce they are now managing the communications on behalf of Stevenage Bioscience Catalyst, marking an exciting development in the business relationship between the two organisations.
About Agility Health Tech
With over 25 years’ experience, Agility Health Tech is a full service consulting and communications agency specialising in the healthcare and life science sectors. From product development to business strategy and marcomms, Agility Health Tech can help advance your products and raise your profile.
AMSBIO reports on a recent published paper** by the Howard Hughes Medical Institute at the Massachusetts Institute of Technology (MIT) investigating why epithelial cells grown in monolayers on a plastic dish are worse at segregating their chromosomes than epithelial cells in vivo or in 3D organoid cultures.This discovery by the MIT researchers could have big implications for scientists growing human tissues in the lab and may also help explain why chromosome mistakes run rampant in cancerous cells – an unanswered question in cancer biology. More broadly, the new…
We are happy to announce the below adversting offer from New Scientist for our members.
Individual Advertising
Standard Branded Advert - £299 (reduced from £599)• Advert branded with logo live for up to 28 days
Enhanced Advert - £450 (reduced from £999)• Same as standard branded advert• Promoted across the website and the homepage• Promoted in our fortnightly newsletter to over 25,000 registered candidates
Targeted Advert - £999 (reduced from £1,599)• Same as an enhanced advert• Advert emailed out to up to 1,000 matching registered candidates
For those clients who have regular…
30 May 2019 - Cambridge UK:
Both One Nucleus and SLAS share a desire to facilitate greater knowledge-sharing, collaboration, connectivity and technology advancement among their respective memberships. The content of One Nucleus and SLAS training courses and events is felt to be very complementary rather than competitive and hence both are keen to collaborate to raise awareness of and engagement in the other’s activities within their own membership groups.
“SLAS is pleased to collaborate with the UK’s One Nucleus to promote and incentivise our members’ participation in what are…
Demonstrating continuing support for immuno-oncology researchers, BioIVT extends excellence in research to help researchers screen novel therapeutics
Westbury, NY – May 29, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will now offer Promega Immune Checkpoint and antibody-dependent cell-mediated cytotoxicity (ADCC) Reporter Bioassays to support immunology and immuno-oncology research. This offering complements BioIVT’s custom assay development services using client-provided cells and reagents.
“BioIVT is…
Plant-expression deal for difficult to produce proteins, vaccines, metabolites and natural proteins
29 May 2019: Norwich, UK Leaf Expression Systems, a contract development and manufacturing organisation specialising in the plant-based expression and production of proteins, vaccines, metabolites and complex natural proteins, has announced the launch of its online list of products available for purchase by researchers working within the life sciences and agricultural industries.
The products are produced in Nicotiana benthamiana using Hypertrans®, Leaf’s Agrobacterium-mediated transient…
Following the continued success of Pharma Integrates, the inaugural Bio Integrates event took place on 22nd May in London. The sold-out conference hosted 315 delegates from across biotech, pharma, investment, charities and patient groups.
The event was opened by Darrin Disley OBE, Chief Executive Officer of Mogrify, who highlighted the importance of collaboration across the science and technology in its ability to deliver effective, affordable and scalable healthcare solutions. He also set the delegates three inspirational challenges: to create an ecosystem of innovation and aspiration; to…
AMSBIO introduces StemFit® Basic04, a next generation feeder-free medium for the maintenance of Induced Pluripotent Stem (iPS) and Embryonic Stem (ES) cells during the reprogramming, expansion and differentiation phases of stem cell culture. With its fully defined and animal-origin free formulation, StemFit® Basic04 is suited to both research studies and translation to cell therapy.With the new StemFit® Basic04 it is now possible to experience market-leading colony expansion (scalable 100-fold expansion / week) allowing single-cell cloning and consistent high performance with a range of…
SOMERSET, N.J. – May 23, 2019 — Catalent (Booth 3101), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, is to launch its new OneBio SuiteSM for the integrated development, manufacturing, and clinical supply of biologic drugs at the BIO International Convention, which takes place at the Pennsylvania Convention Center in Philadelphia, from June 3-6, 2019.
OneBio has been designed specifically to address the challenges facing biologic development companies that are looking to accelerate programs to clinic…
The word “undruggable” has hampered pursuit of the most compelling biological targets, drawing from established opinion that pharmacological modulation was not possible. Scientists at Dogma Therapeutics (“Dogma”) were determined to challenge this assumption. Dogma has discovered an orally-bioavailable small molecule PCSK9 inhibitor. By strategically focusing on small molecule inhibitors, Dogma can readily combine their compounds with current standard of care and dramatically disrupt the health economics of PCSK9-based therapies.
Several antibody-based inhibitors emerged following the rapid…